Neil M Iyengar, Clay Williams, Michael Rogan, Laurie Campbel, Shirley Mertz, Jeremy Block, Maria Ebling, Connie Chen, Justin Doan, Samantha K Kurosky, Timothy J Pluard
Aim: Patients with metastatic breast cancer (MBC) may be vulnerable to changes in healthcare management, safety standards and protocols that occurred during the COVID-19 pandemic. Materials & methods: The REthink Access to Care & Treatment (REACT) survey assessed USA-based patient perspectives on COVID-19-related impacts to their MBC treatment experience between 27 April 2021 and 17 August 2021. Results: Participants (n = 341; 98.5% females, mean age 50.8 years) reported that overall oncology treatment quality was maintained during the pandemic...
April 29, 2024: Future Oncology